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ARTICLE
Antibiotic treatment of rat dams affects bacterial
colonization and causes decreased weight gain
in pups
Monica Vera-Lise Tulstrup1,2, Henrik Munch Roager1,3, Ida Clement Thaarup1, Henrik Lauritz Frandsen1,
Hanne Frøkiær2, Tine Rask Licht 1 & Martin Iain Bahl 1
Intergenerational transmission of bacteria during birth initiates the natural successional
development of the intestinal microbiota in mammals. This process can be disrupted by
antibiotic exposure, potentially affecting early-life microbiota-dependent metabolic pro-
gramming. In the present study, we speciﬁcally investigate the metabolic consequences
of exposing neonate Wistar rats to an antibiotic-perturbed low-diversity microbiota from
birth until weaning, without exposing the pups directly to antibiotics. Here, we show that
pups born from both amoxicillin and vancomycin-treated dams gain less weight than controls.
This was concordant with lower feed intake as well as increased colonic expression of the
PYY satiety hormone gene at weaning. The weight difference persists into adulthood even
though the initial differences in gut microbiota subsided. Our results demonstrate that
early-life exposure to an antibiotic-perturbed low-diversity microbiota is sufﬁcient to cause
changes in body weight persisting into adulthood.
DOI: 10.1038/s42003-018-0140-5 OPEN
1 National Food Institute, Technical University of Denmark, Kemitorvet, DK-2800 Kgs. Lyngby, Denmark. 2 Department of Veterinary and Animal Sciences,
Faculty of Health and Medical Sciences, University of Copenhagen, Grønnegårdsvej 15, DK-1870 Frederiksberg C, Denmark. 3 Department of Nutrition,
Exercise and Sports, Faculty of Science, University of Copenhagen, Rolighedsvej 26, DK-1958 Frederiksberg C, Denmark. Correspondence and requests for
materials should be addressed to M.I.B. (email: mbah@food.dtu.dk)
COMMUNICATIONS BIOLOGY |  (2018) 1:145 | DOI: 10.1038/s42003-018-0140-5 | www.nature.com/commsbio 1
12
34
56
78
9
0
()
:,;
As the number of people in modern societies with obesitycontinues to rise, increasing attention is given to thecommensal intestinal bacterial communities for their role
in affecting energy balance1–4. Extensive evidence from observa-
tional cross-sectional studies in humans, as well as from con-
trolled intervention trials in rodent models, suggests that the
intestinal bacterial communities, which have co-evolved with
mammalian hosts throughout their evolution, play an important
regulatory role for metabolic functions, including weight regula-
tion, fat storage and appetite5–9. A seminal study by Liou et al.
demonstrates that the conserved shifts in microbiota induced by
gastric bypass surgery, including an increase in relative abun-
dance of Escherichia and Akkermansia, are sufﬁcient to cause
weight loss and decreased fat mass in recipient germ-free mice
transplanted with this perturbed microbiota10. This effect may be
due to changes in appetite regulation, which are known in part to
be controlled by bacterial metabolites, such as short-chain fatty
acids and secondary bile acids, binding to speciﬁc G-protein-
coupled receptors on enteroendocrine L cells, thereby triggering
release of satiety hormones11,12. The microbiota has a rapid and
pronounced effect on the L cell transcriptome, and germ-free
mice have increased levels of circulating GLP-1 which suppresses
the intestinal transit rate13. The current understanding of long-
term metabolic programming is that the very early phases of life
are of pivotal importance4,14. During the same time period, an
orchestrated successional development of the bacterial commu-
nity takes place15. Exposure of the host to microbiota disrupting
compounds, such as antibiotics, interferes with this natural pro-
cess, and can thereby have long-lasting metabolic consequences16.
Current knowledge does, however, not provide an unambiguous
link between early-life antibiotic exposure and overweight in later
life17,18, probably because the causations at play are inﬂuenced
by many different factors, including timing of the antibiotic
exposure, diet of the offspring16 and class of antibiotic4,19, and
additionally confounded by factors such as exercise, maternal
obesity20 and infections during pregnancy21.
Results from a series of well-controlled rodent intervention
trials addressing the effect of antibiotic exposure on host weight
gain have been published in recent years. These studies have
mostly focused on early-life exposure to antibiotic compounds
and reveal that subtherapeutic antibiotic treatment (STAT) of
young mice increases adiposity and hormone levels related to
metabolism4, transient perturbation of the microbiota by STAT
in very early life is sufﬁcient to induce sustained effects on body
composition related to obesity16 and that lifelong STAT induces
microbiota changes and enhances the adiposity and insulin
resistance associated with high-fat diet22. Antibiotic therapy at
clinically relevant concentrations during early life has similarly
been shown to have long-term effect on metabolic outcomes and
weight gain19.
Since early-life disruption of the microbiota by antibiotics thus
appears to have consequences for future energy balance regula-
tion, it is important to understand the role of intergenerational
transfer of microbiota. A recent study has shown that a diet,
which has a lowered content of microbiota-accessible carbohy-
drates (MAC), reversibly alters microbial composition in mice
harbouring a human microbiota within a generation. However, if
this diet is sustained over several generations, the changes and
loss of bacterial species become irreversible unless the missing
microbes are administered with the diet23.
In the present study, we investigate the consequences of
antibiotic-induced microbial perturbation in Wistar rat dams
during the peripartum period on appetite regulation and weight
gain in the pups. The dams were orally treated with therapeutic
doses of either amoxicillin, which is known to be partly absorbed
in the small intestine and enter the mammary glands, or with
vancomycin, which is not absorbed into circulation following oral
administration. Both of these antibiotics, which are used exten-
sively in human therapy, inhibit bacterial cell wall biosynthesis24
and have previously been shown to have marked and similar
effects on the microbial community structure in Wistar rats25.
We ﬁnd that pups born to antibiotic-treated dams have altered
intestinal bacterial community composition in early life com-
pared to controls, which gradually recedes into adulthood. Con-
currently, we observe decreased weight gain in pups born to
antibiotic-treated dams, which display a sustained lower body
weight at 14 weeks. At 4 weeks of age, intestinal gene expression
of the satiety hormone PYY in antibiotic treatment groups is
higher compared to controls, which is consistent with the
observation of decreased body weight gain.
Results
Peripartum antibiotics causes lower body weight in pups. In
order to investigate the metabolic consequences of exposure to a
perturbed microbiota at birth and during early life, we compared
groups of rat pups born to dams exposed to either amoxicillin
(AMX) or vancomycin (VAN) to untreated controls (CTR)
(Fig. 1a). No differences in feed intake or animal weight were
observed between groups of dams (Fig. 1b, c). Both AMX and
VAN pups appeared to have a slightly lower feed intake from
week 6 until termination at week 14; however, the difference was
only statistically signiﬁcant (p < 0.05, Student’s t test) for VAN
pups during weeks 7–9 (Fig. 1d). At Day 2, pups (P2D) in the
AMX group were found to have signiﬁcantly lower (p= 0.025,
Student’s t test) average body weight than CTR pups (Fig. 1e, f);
however, this difference, which could in part be explained by
uneven litter sizes at birth until culling at Day 2, disappeared
within the ﬁrst week and no signiﬁcant differences in weight
between groups were observed at weaning of pups at 4 weeks
(P4W) (Fig. 1g). From around week 9, the weight of AMX and
VAN pups was consistently lower than CTR pups and remained
so until termination (Fig. 1e). Furthermore, the epididymal fat
pads, a marker of total body fat26, were reduced in AMX pups at
termination at 14 weeks (P14W) compared to CTR pups and the
same trend was observed for VAN pups (Fig. 1h). Administra-
tion of antibiotics resulted in signiﬁcantly increased (p= 0.039,
Student’s t test) spleen weight at termination in AMX dams, but
no differences in liver weight (Supplementary Fig. 1). We found
no difference in serum levels of the acute-phase protein hap-
toglobin between groups of pups at week 4 (Supplementary
Fig. 2a).
Antibiotic treatment changes the gut microbiota of dams. As
expected, both amoxicillin and vancomycin dramatically reduced
the bacterial α-diversity in the treated dams (Fig. 2a). At the time
of delivery (D0W), the faecal microbiota in dams of both treat-
ment groups (AMX and VAN) clustered separately and distantly
from the CTR group (Fig. 2b, d) and were generally highly
enriched for members of the Proteobacteria phylum, including
Escherichia spp., Morganella spp. and Proteus spp., and depleted
for Firmicutes, including genera known to produce butyrate,
such as Clostridium XIVa (Fig. 2f, g). Interestingly, the bacterial
diversity in faecal samples from dams, collected ∼1 week after
onset of the treatment (D0W), was lower than the diversity in
caecal samples taken 4 weeks later (D4W) (Fig. 2a), which sug-
gests a gradual adaptation to the sustained antibiotic pressure,
which could in part be driven by antibiotic- resistant strains. In
line with this, a principal coordinate analysis (PCoA) based on
unweighted UniFrac distances (Fig. 2d), Bray–Curtis dissim-
ilarity (Supplementary Fig. 3a) as well as relative abundance
distribution patterns at phylum level (Fig. 2f) showed that the
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microbiota of the AMX and VAN dams were more similar to the
CTR after 4 weeks. We have previously shown that faecal and
caecal bacterial diversity and composition in both untreated and
antibiotic-treated rats are similar25. Notably, the total bacterial
load in faecal samples from dams ∼2 days before delivery as
determined by culturing was signiﬁcantly higher (p < 0.0001,
Student’s t test) in AMX and VAN dams than in CTR dams
(Supplementary Fig. 4).
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Fig. 1 Peripartum antibiotic treatment affects weight gain in pups. a Study design. Wistar rat dams (n= 33) were housed individually and randomized to
receive either amoxicillin (AMX), vancomycin (VAN) or water (CTR) by oral gavage daily from 8 days before expected delivery (Day 0) until weaning of
their pups at 4 weeks. Pups did not receive antibiotics directly. The litters were reduced to 6 pups per cage (predominantly male) on Day 2 and further at
2 weeks (n= 5/cage) and at 4 weeks (n= 2/cage) as indicated. Animal weight and feed intake was recorded during the whole study period. Faecal
samples were collected from dams just before expected delivery and dissections (intestinal-, tissue- and blood samples) were performed on pups at 4 time
points; 2 days (P2D), 2 weeks (P2W), 4 weeks (P4W) and 14 weeks (P14W) as well as the dams at weaning (D4W). Feed intake and animal weight for
b,c dams and d,e pups was determined weekly and shown as mean ± SEM with n= 10 (CTR), n= 12 (AMX) and n= 11 (VAN). Pup weights at f P2D and
g P4W for each treatment group are also shown as box-plots with whiskers indicating total range. h Epididymal fat pad weight was determined at
termination of pups (P14W) and depicted as box-plots with whiskers indicating total range. Signiﬁcant differences compared to the CTR group are
indicated in all panels: *p < 0.05
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Pups show delayed intestinal microbiota development. For all
groups of pups, we observed a gradual increase in bacterial
α-diversity reaching approximately the same levels as the
untreated dams after 14 weeks (Fig. 2a). The α-diversity was
signiﬁcantly lower (p= 0.013, Student’s t test) in AMX pups than
in CTR pups at 4 weeks, with the same tendency for the VAN
pups (Fig. 2a). Analysis of unweighted UniFrac distances within
and between groups at different time points as well as PCoA
analysis revealed group-speciﬁc clustering and signiﬁcant differ-
ences in microbial composition in pups at both 2 weeks of age
(P2W) and 4 weeks of age (P4W) (Fig. 2b, e). Separation of
treatment groups was signiﬁcant (p < 0.001, Adonis test) at all
time points with gradually declining separation (P2W; R2= 0.22,
P4W; R2= 0.14 and P14W; R2= 0.088). Analysis based on
Bray–Curtis dissimilarity showed similar clustering (Supple-
mentary Fig. 3b). Analysis of the number of shared OTUs
between pups within the control group and pups between the
control group and antibiotic treatment groups showed that at
4 weeks, but not at 2 and 14 weeks, there were signiﬁcantly fewer
(p < 0.0001, Mann–Whitney test) shared OTUs between
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treatment and the control group, than within the control group
(Fig. 2c). This indicated that some of the shared OTUs in the
CTR P4W pups are lacking in both the AMX and VAN pups. To
further investigate this, we focused on OTUs that were omni-
present in the CTR animals at 4 weeks and determined their
prevalence in the antibiotic-exposed pups of the same age (Sup-
plementary Fig. 5a). We noted an interesting pattern for
OTU_114 (99% homology to Alistipes ihumii strain AP11), which
was absent in nearly all animals in both the AMX and VAN
groups at P4W groups (whilst present in all CTR animals). We
further found that this particular OTU remained absent in all
VAN (11/11) and most AMX (9/12) pups to the age of 14 weeks
and was also not present in the antibiotic-treated dams D0W at
the time of giving birth (Supplementary Fig. 5b). At the genus
level, the composition of the microbiota of the 2-week-old pups
(P2W) of the antibiotic-treated dams differed signiﬁcantly from
CTR pups in several genera. This included a higher relative
abundance of Clostridium XI, which contains Peptoclostridium
difﬁcile (formerly Clostridium difﬁcile) in both AMX and VAN
pups (Padj= 0.019 and Padj= 0.022, respectively, permutation-
based t test) (Fig. 2g). At 4 weeks (P4W), only a few genera
differed signiﬁcantly from the CTR, namely Escherichia, which
was higher in both AMX and VAN pups (Padj= 0.042 and Padj=
0.049, respectively), and Ruminococcus (Padj= 0.049), which was
less abundant in VAN pups compared to CTR pups. At the of age
14 weeks (P14W), the pup microbiotas of all groups clustered
together (Fig. 2e and Supplementary Fig. 3b) and no differences
in UniFrac distances within or between treatment groups
(Fig. 2b), nor within or between bacterial groups at genus level
were found (Fig. 2g). So the initially reduced diversity in the AMX
and VAN pups, indicating a delayed microbial development, was
mostly normalized at 14 weeks.
Peripartum antibiotics affects SCFA production in pups. To
understand whether the observed differences in microbiota in
4-week-old pups caused differences in bacterial activity related
to energy extraction and signalling, we investigated short-chain
fatty acid composition in the caecum at this age. No signiﬁcant
differences in acetate levels between groups were found (Fig. 3a).
Compared to CTR pups, the AMX pups had signiﬁcantly lower
(p= 0.035, Student’s t test) concentrations of butyrate, with the
same trend observed for VAN, while the VAN pups also had
lower concentrations of propionate (p= 0.0087, Student’s t test)
(Fig. 3b, c). The observed reduction in butyrate in the antibiotic
groups is consistent with delayed microbial development, but was
not accompanied by enlarged caecum size as noted for the dams
(Fig. 3d). At 14 weeks of age, the caecum size was found to be
slightly reduced in the VAN group compared to the control
group; however, this was attributed to a strong correlation
between caecum weight and total body weight (Spearman’s rho=
0.62, p= 0.0001). The caecal pH of VAN dams was increased
compared to CTR dams; however, no difference in pH between
the three groups of pups was found (Fig. 3e). Finally, no differ-
ences in faecal gross energy were found between the different
groups of pups at 4 weeks (Fig. 3f), suggesting that the differences
in body weight observed between the groups of pups were not
sufﬁciently explained by differences in microbial energy extrac-
tion capacity.
Appetite regulation is affected by peripartum antibiotics. Since
we observed a reduced body weight together with a reduced feed
intake in the pups that received an antibiotic-perturbed low-
diversity microbiota, we considered that expression of intestinal
genes potentially affected by the microbiota and related to
appetite regulation may be involved. Indeed, expression of the
satiety hormone Peptide YY (PYY) gene was higher in both AMX
and VAN pups (p= 0.0075 and p= 0.0012, respectively, Stu-
dent’s t test) at the age of 4 weeks compared to CTR pups, in
accordance with the differences observed in the antibiotic-treated
dams (Fig. 4a). No differences in PYY expression were observed
in pups at 2 weeks despite signiﬁcant differences in microbial
community composition. At the age of 14 weeks also, no differ-
ences between groups were observed in the pups, suggesting a
transitory effect on colonic PYY gene expression in the pups of
antibiotic-treated dams. Colonic expression of the incretin
Glucagon-like peptide-1 (GLP-1) gene was also higher in AMX-
treated dams (Fig. 4b). However, no difference was observed
between groups of pups at any of the sampling times, which
was supported by no differences in serum GLP-1 concentrations
in 4-week-old pups (Supplementary Fig. 2b). Expression of
genes encoding G-protein-coupled receptors GPR41 and
GPR43 speciﬁc for short-chain fatty acids (SCFAs) did not differ
in dams nor pups at any of the sampling points (Fig. 4c, d)
despite changed SCFA levels in antibiotic- treated dams and some
groups of pups. Expression of the bile acid-speciﬁc TGR5
membrane receptor gene in VAN pups was notably lower (p=
0.0002, Mann–Whitney test) at 2 weeks, and tended to be lower
also at 4 weeks. In AMX pups, the expression of this gene was
lower (p= 0.0090, Student’s t test) at 4 weeks (Fig. 4e). Finally,
the expression of the bile acid-sensing nuclear farnesoid X
receptor (FXR) was not different between groups of dams and
pups, respectively (Fig. 4f). Together, this suggests that changes
in colonic gene expression related to appetite regulation may
contribute to the observed lower body weight and lower feed
intake in the AMX and VAN pups.
Peripartum antibiotics do not affect bile acid levels in pups.
Since we observed reduced colonic TGR5 expression in pups of
antibiotic-treated dams at the age of 4 weeks, we speculated that
this could be linked to differences in bile acid proﬁles resulting
from a delayed gut microbiota development in the pups. Anti-
biotics had a dramatic effect on the serum bile acid proﬁle in dams
Fig. 2 Antibiotic treatment affects microbiota in both treated dams and their pups. a Bacterial diversity in faecal/caecal content estimated as Shannon
diversity index in dams n= 10 (CTR), n= 12 (AMX) and n= 11 (VAN) at the time of giving birth (D0W, faecal sample) and 4 weeks later (D4W, caecal
sample) as well as pups at 2 days (P2D, intestinal sample), 2 weeks (P2W), 4 weeks (P4W) and 14 weeks (P14W) (all caecal samples) of age shown as
box-plots with whisker indicating total range. b Boxplot of unweighted UniFrac distances calculated from caecal microbial composition within all groups
(grey) and between groups (yellow) of dams (D0W and D4W) and pups (P2W, P4W and P14W) and c boxplot showing numbers of shared OTUs
between animals within the CTR group and between the CTR and antibiotic treatment groups of pups at P2D, P4W and P14W. Whisker indicates total
range. Principal coordinate analysis (PCoA) based on unweighted UniFrac distances of d faecal and caecal samples from dams (D0W and D4W) and
e caecal samples from pups (P2W, P4W and P14W) coloured according to treatment group. f Bacterial composition in dams and pups shown as average
relative abundance at the phylum level. g Heatmap depicting log10 relative abundance scores for faecal and caecal agglomerated genera present in >50% of
samples. Results are shown for dams at delivery (D0W) and dams 4 weeks after delivery (D4W) as well as pups at different ages (P2D, P2W, P4W and
P14W). In panels a, b and c: *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001 and in panel g FDR-corrected p values compared to the CTR group are shown
*q < 0.05; **q < 0.01. The left-hand colour bar shows the taxonomic classiﬁcation at the phylum level
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(Fig. 5a–c), characterized by a reduction of secondary bile acids
and an overall increase in bile acids in the vancomycin-treated
dams. Principal component analysis (PCA) of serum bile acids
in the pups revealed differences according to age, but independent
of peripartum antibiotics treatment (Fig. 5a and supplementary
Fig. 6a). Serum bile acid proﬁles were very similar among pups
at 2 weeks of age, as shown by the tight clustering of P2W samples
in the PCA plot (Fig. 5a). After weaning, at 4 weeks of age,
the P4W samples were more scattered (Fig. 5a), probably driven
by the microbiota differences observed at this time point (Fig. 2e).
Finally, at the age of 14 weeks, the serum bile acid proﬁle of
the pups were very similar to that of CTR dams (D4W), as
observed by the clustering of P14W samples with the CTR dams
(D4W) in the PCA plot (Fig. 5a). The collective mean con-
centration of serum bile acids in pups differed with age, peaking
at the age of 4 weeks, at which time point also secondary bile
acids were ﬁrst markedly observed, and reached a proﬁle similar to
that of CTR dams at the age of 14 weeks (Fig. 5b). The bile acid
proﬁles of the 2-week-old pups were dominated by conjugated
primary bile acids, while the bile acid proﬁles at 4 weeks were
dominated by de-conjugated primary bile acids, and the bile
acid proﬁles at 14 weeks appeared not to be dominated by any
speciﬁc bile acid group. The individual serum bile acid con-
centrations in AMX and VAN pups were not signiﬁcantly
different from CTR pups at any of the time points, possibly due
to large inter-individual variations, while several serum bile acids
in the antibiotic-treated dams differed from CTR dams (Fig. 5c).
In colonic content from pups at 4 weeks, no differences between
groups of pups were detected for any of the quantiﬁed bile
acids (Fig. 5d), although a PCA plot suggested a slightly higher
inter-individual variation within the bile acid proﬁle of AMX and
VAN pups (Fig. 5e and supplementary Fig. 6b) compared to CTR.
Thus, peripartum antibiotics did not signiﬁcantly affect bile acid
proﬁles in pups.
Appetite regulation is associated with speciﬁc bacterial groups.
To investigate associations between the gut microbiota and
intestinal gene expression levels of satiety hormones (GLP-1 and
PYY), SCFA receptors (GPR41 and GPR43), bile acid receptors
(FXR and TGR5) and caecal SCFA levels in pups at 4 weeks,
we conducted a correlation analysis at the genus level (Fig. 6a).
Bacterial α-diversity (Shannon and richness indices) in the cae-
cum correlated positively with caecal butyrate levels. Additionally,
α-diversity was negatively associated with Escherichia spp., which
was overrepresented in both antibiotic-treated groups at 4 weeks
(Fig. 2g). Notably, Escherichia spp. was found to be the only genus
that correlated positively with both PYY (Spearman’s rho= 0.41,
p= 0.019) and GLP-1 (Spearman’s rho= 0.52, p= 0.002) gene
expression in colonic tissue and also correlated positively with
expression of FXR (Spearman’s rho= 0.50, p= 0.003). Gene
expression of FXR, but not TGR5, was strongly correlated to the
gene expression of satiety hormones PYY and GLP-1 (Spearman’s
rho= 0.57, p= 0.0005 and rho= 0.65, p= 0.00005, respectively).
The strongest negative correlations with appetite hormone
expression were found for Staphylococcus spp. (Spearman’s rho=
−0.51, p= 0.002) and Hespellia spp. (Spearman’s rho=−0.47,
p= 0.006) for PYY and GLP-1, respectively. Colonic expression of
bile acid receptors TGR5 and to a lesser extent FXR correlated
with several speciﬁc primary and secondary bile acids in both
serum and colonic content (Fig. 6b). Collectively, only few bac-
terial groups were found to correlate to expression of appetite
hormones GLP-1 and PYY.
Discussion
Here we report that exposure of conventional Wistar rat dams to
either amoxicillin or vancomycin during the peripartum period
caused a sustained lower body weight in their male pups, as
compared to a control group not exposed to antibiotics. The
0
1
2
3
**
0
5
10
15
*
0
5
10
15
20
25
*
****
****
16
17
18
19
C
T
R
A
M
X
V
A
N
P4W
C
T
R
A
M
X
V
A
N
P4W
P
ro
pi
on
at
e 
co
nc
en
tr
at
io
n
(m
M
)
B
ut
yr
at
e 
co
nc
en
tr
at
io
n 
(m
M
)
C
ae
cu
m
 w
ei
gh
t (
g)
C
T
R
A
M
X
V
A
N
C
T
R
A
M
X
V
A
N
C
T
R
A
M
X
V
A
N
D4W P4W
C
T
R
A
M
X
V
A
N
P4WP14W
C
T
R
A
M
X
V
A
N
C
T
R
A
M
X
V
A
N
D4W P14W
pH
 in
 c
ae
cu
m
***
8.0
7.5
7.0
6.5
6.0
5.5
5.0
F
ae
ca
l g
ro
ss
 e
ne
rg
y 
(k
J/
g)
0
10
20
30
A
ce
ta
te
 c
on
ce
nt
ra
tio
n 
(m
M
)
C
T
R
A
M
X
V
A
N
P4W
a b c
d e f
Fig. 3 Antibiotic treatment of dams affects short-chain fatty acid levels in pups. Median concentrations of a acetate, b propionate and c butyrate in
the caecum of 4-week-old pups. d Caecum weight and e caecal pH of dams 4 weeks after delivery (D4W) and pups at 4 (P4W) and 14 (P14W) weeks
of age. f Faecal gross energy in samples from pups at 4 weeks (P4W). All panels show box-plots with whiskers indicating total range. *p < 0.05; **p < 0.01;
***p < 0.001 and ****p < 0.001
ARTICLE COMMUNICATIONS BIOLOGY | DOI: 10.1038/s42003-018-0140-5
6 COMMUNICATIONS BIOLOGY |  (2018) 1:145 | DOI: 10.1038/s42003-018-0140-5 | www.nature.com/commsbio
reduced body weight was also reﬂected in signiﬁcantly reduced
epididymal fat pats at 14 weeks of age. The pups did not directly
receive antibiotics at any time, although a low exposure through
coprophagy may occur and additionally amoxicillin may poten-
tially be transferred during lactation due to intestinal absorption
in the dams, which is an intrinsic limitation of the experimental
design. Previous studies in rodents have, however, indicated such
transfer to be minimal27. We therefore propose that effects on
growth parameters were driven primarily by an antibiotic-
induced altered microbial transmission from dams during birth
and early life, but cannot rule out direct effects of low doses of
antibiotics. This is in line with a recent study demonstrating that
colonization of germ-free mice with antibiotic-altered microbial
communities may induce changes in the metabolic phenotype16.
Colonization of germ-free IL10-deﬁcient mouse dams with
antibiotic-perturbed bacterial communities as well as peripartum
antibiotic treatments of dams has also been shown to enhance
colitis in pups28. Importantly, these previous studies have indi-
cated a risk of lasting metabolic consequences despite recovery of
the intestinal microbial community. In the current study, we
found a gradual recovery of the disturbed pup microbiota, which
at 14 weeks of age was very similar to the CTR group at the genus
level, although grouping was still indicated by the Adonis test
based on the UniFrac distance matrix. The number of shared
OTUs between animals within the CTR groups at 4 weeks (P4W)
was signiﬁcantly higher than the number of shared OTUs
between treatment groups. This observation is a clear indication
that some OTUs are absent in the AMX and VAN groups at this
time point. An interesting example of this was observed for
OTU_114, classiﬁed as Alistipes ihumii, which is omnipresent
in all animals in the CTR group at 4 weeks, but reduced to
below-detection level for almost all AMX and VAN pups at P4W
and remained so until P14W. In general, Alistipes spp. are strict
anaerobes and have previously been reported to be
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underrepresented in the caecum and colon of undernourished
mice29. At 14 weeks, the body weight of both AMX and VAN
pups appeared to approach a plateau signiﬁcantly lower than that
observed for the control group. This observation of stunted
growth is different from several recent reports of increased weight
gain and adiposity as a consequence of early-life antibiotic
exposure4,22. However, it is important to recognize the intrinsic
variable parameters associated with antibiotic treatment, includ-
ing the mode-of-action of the antibiotic compound as well as the
concentration, timing and duration of exposure. A recent review
proposed a pathway for antibiotic-mediated weight modulation
inferring that early-life perturbation of the microbial community
by high-dose antibiotics can lead to stunted growth due to loss
of microbiota-derived calories30, which is in line with previous
work elucidating the role of the microbiota in relation to energy
harvest and fat storage5,31. Consistent with our ﬁndings, it was
recently reported that stunted growth of malnourished Malawian
children is associated with delayed maturation of the gut
microbiota32. They demonstrated that introducing Ruminococcus
gnavus and Clostridium symbiosum to this immature microbiota
ameliorated growth and metabolic abnormalities in recipient
germ-free mice. Interestingly, we found reduced Ruminococcus
spp. in the VAN-treated animals at 4 weeks and a negative
correlation between this genus and gene expression of the satiety
hormone PYY. Ruminococcus bromii has also previously been
linked to obesity and resistant starch degradation in humans33,34.
Although several studies thus link antibiotic-induced microbial
pertubation to changes in metabolic programming, it has,
however, also been shown that antibiotic treatment may elicit
microbiome-independent changes in host metabolites35.
Microbiome-independent effects of antibiotics may therefore also
contribute to the observed effects in the current study.
The observed differences in weight gain during the ﬁrst
14 weeks of life may be caused by differences in feed intake,
altered energy extraction from the feed or a combination of these.
We generally observed a minor reduction in feed intake for
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antibiotic pups after weaning, especially for VAN pups, which is
consistent with a previous study showing reduced feed intake for
adult rats treated orally with amoxicillin25. No difference in faecal
gross energy at 4 weeks was found, although differences in
nitrogen and fat absorption cannot be ruled out. Since there were
also no differences in animal weight and only minor differences
in microbial composition between groups of pups at 4 weeks, we
ﬁnd it unlikely that microbiota-driven differences in energy
extraction were sufﬁcient to cause the observed 6–7% lower body
weight of AMX and VAN pups aged 14 weeks.
We thus considered that early-life programming of appetite
regulation could be involved in later-life weight regulation. The
bacterial diversity, but not the total bacterial load, in the faeces of
the antibiotic-treated dams shortly before birth was signiﬁcantly
reduced as compared to control animals, which is consistent with
previous studies25,36. It has also previously been shown that the
vaginal microbiota is altered by antibiotics during pregnancy37.
Collectively, it is likely that the initial bacterial seeding of the pups
of antibiotic-treated dams was very different from CTR dams.
Speciﬁcally, the pups were initially exposed to a faecal microbiota
characterized by low bacterial alpha-diversity with a relatively
high abundance of Enterobacteriales, including Escherichia spp.,
Morganella spp. and Proteus spp. The increased levels of these
facultative anaerobes in the dams may be explained by depletion
of butyrate-producing Clostridia causing decreased levels of
butyrate25, which in turn has been reported to fuel aerobic
pathogen expansion due to increased epithelial oxygenation38.
The high relative abundance of Enterobacteriales in the dams at
the time of giving birth was, however, not directly reﬂected in the
pups microbiota before the age of 4 weeks, at which point the
alpha-diversity was lower compared to CTR pups and the relative
abundance of Escherichia spp. was higher in both the AMX and
VAN pups. Interestingly, the lower alpha-diversity, the increased
PYY expression and the reduced weight ﬁrst became apparent
after the pups had started on solid foods. Leptin ingested during
lactation may have initially regulated food intake and growth in
all pups similarly39,40 so that differences in appetite induced by a
low-diversity microbiota only became noticeable after weaning.
Escherichia coli has previously been associated with body mass
index and appetite regulation41. The suggested mechanisms
behind this association include expression of the ClpB protein, a
mimetic of the host α-MSH hormone known to induce satiety42,
bacterial production of the tryptophan metabolite indole, which
modulates GLP-1 release from enteroendocrine L cells43 and
bacterial lipopolysaccharide binding to TLR4 receptors in the
vagal afferents signalling to the brain44. In line with this, we
identiﬁed signiﬁcant positive correlations between intestinal
Escherichia spp. relative abundance and colonic gene expression
of satiety proteins GLP-1 and PYY in the pups across all treat-
ment groups as well as signiﬁcantly higher gene expression of
PYY in pups of antibiotic-treated dams at 4 weeks. Antibiotics
have previously been shown to increase postprandial secretion of
PYY in humans45. A link between Escherichia spp. and weight
regulation is consistent with a previous report of weight loss
in germ-free mice receiving caecal microbiota from Roux-en-Y
gastric bypass-treated mice characterized by increased abundance
of Escherichia, Akkermansia and Alistipes10.
We have previously reported that antibiotic treatment causes a
decrease in the levels of microbially produced SCFAs and increases
caecal size and luminal pH25. Also in the present study, antibiotic
treatment of pregnant dams increased caecal size and pH, con-
sistent with an observed reduction in butyrate-producing Firmi-
cutes. In the 4-week-old pups of antibiotic-treated dams, we found a
reduction in caecal butyrate and propionate levels in the AMX and
VAN pups, respectively. Very few differences in microbiota at the
genus level were seen at this age, but lower levels of the butyrate-
producing Ruminococcus spp., were detected in the VAN pups.
Propionate activates PYY and GLP-1 release from L cells in
humans46,47, and it has recently been shown that GPR43 deﬁciency
impaired the release of GLP-1 and PYY after administration of
propionate11. In the current study, no differences in gene expression
of SCFA receptors GPR41 and GPR43 were seen between treatment
groups at any age in the pups, which suggests that changes in
expression patterns of these receptors did not drive the observed
metabolic differences in the pups, although differences at the pro-
tein level cannot be ruled out.
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Antibiotic treatment of dams had a major effect on serum bile
acid proﬁles characterized by a reduction of secondary bile acids in
both AMX and VAN groups as compared to CTR. Since the gen-
eration of secondary bile acids largely depends on microbial
transformation processes, the observed decreased concentration
is in accordance with antibiotic-driven alteration of the gut
microbiota in the dams and is consistent with previous studies48–50.
An increase in primary bile acids (both conjugated and de-con-
jugated) as well as in the total bile acid pool occurred in the VAN
dams but not in the AMX dams as compared to the CTR group.
The difference between the antibiotic groups is likely to be
explained by differences within the lactobacilli, which are resis-
tant to vancomycin and capable of performing de-conjugation via
bile salt hydrolase activity51.
The differences in bile acid proﬁles of dams were not trans-
ferred to the pups, as bile acid proﬁles measured in pup serum at
ages of 2, 4 and 14 weeks and in colon content at 4 weeks did not
show any differences between the treatment groups. We did,
however, ﬁnd a down-regulation of expression of the TGR5
receptor in both 2- and 4-week-old pups of antibiotic-treated
dams, which is an important ligand of secondary bile acids. Bile
acids binding to the TGR5 receptor on enteroendocrine L cells
may stimulate the secretion of satiety hormones PYY and GLP-
152,53 and bile acid infusions have been shown to increase plasma
PYY in a dose-dependent manner54.
The observed temporal development in serum bile acid proﬁles
with age, irrespective of the treatment group, is consistent with
the co-occurring successional development of the gut microbiota.
The immature gut microbiota in early life is expected to have
limited bile acid biotransformation capacity consistent with the
observed low levels of secondary and de-conjugated primary bile
acids in 2-week-old pups. This was succeeded by a dramatic
increase in total serum concentration of bile acids at 4 weeks,
driven primarily by secondary and unconjugated primary bile
acids. The total amount of bile acids then decreased again in the
14-week-old pups to resemble the level of bile acids found in
control dams. An observed, spike in total serum bile acid levels at
4 weeks has previously been recognized in Wistar rats55 and
could be related to the shift from breast milk to solid diet during
weaning. Indeed, Massimi et al. tracked the levels of CYP7A1
mRNA, encoding a rate-limiting enzyme in the bile acid synthesis
pathway in Sprague Dawley rats, and found a distinctive peak
around day 22, at which point weaning took place56. Coincident
with weaning, the leptin levels in rats increase39 and leptin has
been suggested to regulate bile salt metabolism57.
In conclusion, we found that peripartum antibiotic treatment
of rat dams caused a delay in successional microbiota develop-
ment and sustained lower adult body weight in their pups.
Concurrent with the lower body weight, we found differences in
appetite hormone PYY and bile acid receptor TGR5 expression
levels in colonic tissue as well as decreased levels of caecal SCFA
levels in 4-week-old pups. These results are consistent with recent
studies substantiating a microbial impact on early-life metabolic
programming and provide new knowledge concerning potential
risks associated with antibiotic administration during pregnancy.
Methods
Animals and housing. Time-mated speciﬁc pathogen-free female Wistar Hann-
over rats (n= 33), with a weight of 200 ± 10 g, were obtained from Taconic
Biosciences (Lille Skensved, Denmark). Upon arrival on gestation day (GD) 8, the
animals were housed individually under controlled environmental conditions (12-h
reverse light/dark cycles, temperature 21.5 ± 0.3 °C, relative humidity 51.3 ± 3.1%
and 8–10 air changes per hour). Animals had access to ad libitum water and feed
(Altromin 1314 until giving birth and then Altromin 1324, Altromin Spezialfutter
GmbH, Germany) throughout the study. Animal experiments were carried out at
the DTU National Food Institute (Mørkhøj, Denmark) facilities. Ethical approval
for the study was given by the Danish Animal Experiments Inspectorate with
authorization number 2012-15-2934-00089, C2. The experiments were overseen by
the DTU National Food Institutes in-house Animal Welfare Committee for animal
care and use. Animals were monitored twice a day.
Experimental design. Following a 5-day acclimatization period, dams were equally
allocated into three treatment groups (with 10–12 animals in each group) based on
weight. Blinding was not implemented during the animal trial due to practical
reasons. Antibiotic treatment of dams started on GD 14, which is 8 days before
expected birth, and consisted of a daily dosage of 0.5 mL of antibiotic solution
containing 60 mgmL−1 amoxicillin, Sigma-Aldrich A8523 (AMX, n= 12), 8 mg
mL−1 vancomycin, Sigma-Aldrich 861987 (VAN, n= 11) or water (CTR, n= 10)
by oral gavage. Antibiotic treatment continued until pups were weaned at 4 weeks
of age. The scale weight of pups as well as feed and water intake after weaning was
determined weekly during the study until termination at week 14 (Fig. 1a). Litters
were reduced to 6 pups per dam at 2 days of age (P2D), 5 pups per dam at 2 weeks
of age (P2W) and further to 2 animals following weaning at 4 weeks of age (P4W)
with a preference for male animals remaining. Small litters were supplemented with
excess pups from other dams within the same treatment group at P2D. At P2D,
P2W, P4W and P14W, the culled animals from each litter were dissected for
further analysis, including collection of blood, intestinal tissue and content from
caecum and colon and weighing spleen, liver and caecum as well as determining
pH in the latter (OrionTM 3-star benchtop pH meter, Thermo Fisher Scientiﬁc).
Faecal samples collected from dams 2 days before expected delivery (D0W) as well
as samples taken during dissection of dams at weaning (D4W) were also included
for analysis.
Extraction of DNA and amplicon library preparation. Intestinal samples for
DNA extraction were stored at −80 °C until analysis. Community DNA was
extracted from faecal samples collected from dams just prior to delivery (D0W),
from total gut content of 2-day-old female pups (P2D) and from caecal content of
dams and male pups (D4W, P2W, P4W and P14W) using the MoBio PowerLyzer®
Power Soil® DNA Isolation Kit (MoBio Laboratories, Carlsbad, CA) according to
the manufacturer’s recommendations with minor modiﬁcations. A maximum of
200-mg samples was used for extraction and the bead beating step was conducted
twice at 30 cycles s−1 for 5 min with a 10-min break in-between (Retsch MM 300
mixer mill). DNA concentrations were measured ﬂuorometrically with the Qubit
dsDNA HS kit (Life Technologies). The bacterial community composition was
determined by ampliﬁcation and sequencing of the V3-region in the 16S rRNA
gene using the Ion Torrent PGM platform (Life Technologies) as previously
described58. Brieﬂy, the V3-region of the 16S rRNA gene was ampliﬁed using a
universal forward primer (PBU 5′-A-adaptor-TCAG-barcode-CCTACGGGAGG-
CAGCAG-3′) with a unique 10–12-bp barcode for each bacterial community
(IonXpress barcode as suggested by the supplier, Life Technologies) and a universal
reverse primer (PBR 5′-trP1-adapter-ATTACCGCGGCTGCTGG-3′). The PCR
products were puriﬁed using the MAGBIO HigPrep™ PCR-96 well protocol
according to the manufacturer’s recommendations, and DNA concentrations were
determined with Qubit HS assay. Three amplicon libraries were constructed con-
taining material from P2D/D0W, P2W/P4W and D4W/P14W, respectively, by
mixing equal amounts of PCR products from each original community. Sequencing
of the three libraries was performed on 318-chips for Ion Torrent sequencing using
the Ion OneTouch™200 Template Kit v2 DL.
Bacterial community composition. Sequence data in FASTQ format was initially
processed in CLC Genomic Workbench (version 8.5, Qiagen, Aarhus, Denmark) in
order to de-multiplex and remove sequencing primers, retaining reads only if both
forward and reverse primers were correctly identiﬁed with 100% homology as
previously described58. Next, operational taxonomic units (OTUs) were picked de
novo using UPARSE59 and an OTU table was generated. Taxonomical classiﬁca-
tion of OTUs was assigned using the Ribosomal Database Project multiclassiﬁer
version 2.10.1 and the RDP database60 with conﬁdence threshold set to 0.5 as
recommended for sequences shorter than 250 bp61. Further downstream proces-
sing was performed in QIIME62. A phylogenetic tree was generated (make_phy-
logeny.py) and rooted to an archaeal species following alignment of all OTUs. The
OTU table was ﬁltered to exclude singletons and include only OTUs assigned as
bacteria (excluding the Cyanobacteria/Chloroplast group), and present in at least
two samples, resulting in a total of 1426 OTUs and a median read depth of 32,906
(range 13,684–124,303). The QIIME workﬂow core_diversity_analysis.py was used
to generate alpha- and beta-diversity indices and relative abundance tables at
different taxonomical levels with a rareﬁed depth of 13,600 reads, including all
samples except P2D. To determine UniFrac distances within and between groups
of animals, the make_distance_boxplots.py script was used. The script compar-
e_categories.py was used to perform Adonis tests on bacterial community com-
position. To determine the number of shared OTUs, the generated OUT table was
ﬁrst rareﬁed to 10,000 reads per sample using single_rarefaction.py and the script
shared_phylotypes.py was used. A heatmap was generated at the genus level,
including only those genera observed in a minimum of 50% across all samples and
coloured according to average log10 relative abundances within each group/time
point. The samples from 2-day-old pups (P2D) contained only 180 OTUs in reads
assigned to bacteria with a median read depth of 8639 (range 1484–42,149) and
were analyzed only for phylum-level distribution.
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Gene expression analysis. Approximately 1 cm of colon tissue from dissected
animals (D4W, P2W, P4W and P14W), stored in RNAlater® (Life Technologies)
at −80 °C, was homogenized in lysis buffer (MagMAX-96 RNA Isolation Kit;
Ambion, Austin, TX) with glass beads using a FastPrep instrument (FP120, Bio
101, Thermo Savant; Qbiogene). Total RNA from the homogenized samples was
extracted by MagMAX Express (Applied Biosystems) by using the MagMAX-96
RNA Isolation Kit (AM 1830, Ambion) for tissues, following the supplier’s
recommendations. Next, cDNA was produced from ∼500 ng of total RNA by using
the High-Capacity cDNA Reverse Transcriptase Kit (Applied Biosystems, Foster
City, CA, USA) according to the manufacturer's recommendations. The resulting
cDNA was used as template for the qPCR reaction. The TaqMan® Fast Universal
Master Mix (2×) (4366073, Applied Biosystems, Thermo Fisher Scientiﬁc, Wal-
tham, USA) was used together with speciﬁc TaqMan primers to assay for GLP-1,
PYY and GPR41, and GPR43, FXR and TGR5 (Supplementary Table 1). The
cDNA was ampliﬁed in duplicate on a StepOnePlus instrument (Applied Biosys-
tems). Gene expression was calculated by the comparative cycle threshold (CT)
method. The geometrical mean of ACTB and HPRT1 gene expression was used for
normalization of the qPCR results. The expression of target genes was normalized
to the geometrical mean of the reference genes by calculating ΔCT= CT(target)−CT
(GEOMEAN reference). Fold change in gene expression was calculated as 2−ΔΔCT,
where ΔΔCT= ΔCT(sample)−ΔCT(calibrator) and the mean ΔCT of samples from
control rats was used as a calibrator. Log2(ΔΔCT) was taken to illustrate the fold
change of the treatment groups compared to the control group, centred at zero.
Short-chain fatty acid analysis. Caecum samples from 4-week-old pups (P4W)
were analyzed for acetic acid, propionic acid and butyric acid by gas
chromatography–mass spectrometry (GC–MS) by MS-Omics, Copenhagen, based
on an established method63. Brieﬂy, the samples were homogenized in Milli-Q
water by ultrasonication, acidiﬁed with HCl, supernatants were transferred to GC-
vials and internal standards were added. The samples were then analyzed in ran-
dom order by GC–MS and processed with software based on the PARAFAC2
model. Quantiﬁed values are calculated assuming that 1 mg of faeces corresponds
to a volume of 1 µL.
Faecal gross energy analysis. Faecal gross energy from 4-week-old pups (P4W)
was assessed using a BOMB calorimeter C6000 isoperibol (IKA, Staufen, Germany)
according to the manufacturer’s recommendations. Brieﬂy, the faecal samples were
dried at 50 °C for 2 days before burning them with a ﬁxed amount of benzoic acid
(one pill, C723, IKA) as an accelerant. Results were calculated in J g−1 according to
the isoperibol mode of the device.
Bile acid proﬁling. LC–MS-grade acetonitrile, methanol and acetic acid were
obtained from Sigma-Aldrich (St. Louis, MO, USA). All aqueous solutions were
prepared using ultrapore water obtained from a Millipore Milli-Q Gradient
A10 system (Millipore, Bedford, MA). Oasis HLB 1 cc cartridges (30 mgmL−1)
were purchased from Waters (Milford, MA, USA).
Authentic compounds of 12 unconjugated, 9 taurine conjugated and 5 glycine-
conjugated bile acids were ordered from either Sigma-Aldrich (Sigma-Aldrich,
Schnelldorf, Germany) or Steraloids (Newport, RI, USA). Of these, four bile acids,
which were absent in the rats, were used as internal standards (IS), namely
glycoursodeoxycholic acid (GUDCA), dehydrocholic acid (DHCA), 23-
nordeoxycholic acid (23-NDCA) and glycolithocholic acid (GLCA). The other
22 bile acids, which were to be quantiﬁed, included tauro-ω-muricholic acid
(TωMCA), tauro-α-muricholic acid (TαMCA), tauro-β-muricholic acid (TβMCA),
tauroursodeoxycholic acid (TUDCA), taurohyodeoxycholic acid (THDCA),
taurocholic acid (TCA), glycocholic acid (GCA), glycohyodeoxycholic acid
(GHDCA), taurochenodeoxycholic acid (TCDCA), taurodeoxycholic acid (TDCA),
ω-muricholic acid (ωMCA), α-muricholic acid (αMCA), 7-ketodeoxycholic acid
(7-KDCA), glycochenodeoxycholic acid (GCDCA), β-muricholic acid (βMCA),
hyocholic acid (HCA), taurolithocholic acid (TLCA), cholic acid (CA),
ursodeoxycholic acid (UDCA), hyodeoxycholic acid (HDCA), chenodeoxycholic
acid (CDCA) and deoxycholic acid (DCA). Details on the authentic compounds
are provided in Supplementary Table 2.
Stock solutions (1 mgmL−1) of 26 bile acids were individually prepared from
their authentic compounds. Conjugated bile acids were prepared in 50% methanol
and unconjugated bile acids were prepared in methanol. An IS solution containing
four bile acids, namely GUDCA, DHCA, 23-NDCA and GLCA (1 mgmL−1 each),
was prepared in 50% methanol. The other 22 bile acids were mixed (BA mix) and
further diluted with 50% methanol to give ﬁnal concentrations of 0.01 µg mL−1,
0.1 µg mL−1, 1 µg mL−1 and 4 µg mL−1. Serum samples from dams at termination
and pups at week 2, 4 and 14 were prepared in Eppendorf tubes where an aliquot of
the IS solution (50 µL, 1 µg mL−1) had been dried with nitrogen. To each tube,
40 µL of serum and 100 µL of acetonitrile were mixed, vortexed and left at −20 °C
for 30 min to precipitate the proteins. Lumen content of colon (100–150 mg) from
pups at week 4 was diluted 1:2 with the IS solution (4 µg mL−1), vortexed for 10 s
and centrifuged at 16,000 × g, 4 °C for 10 min. Subsequently, 150 µL of colonic
evacuate was mixed with 350 µL of acetonitrile, vortexed and then left at −20 °C for
20 min to precipitate the proteins. After precipitation of proteins, serum and colon
samples were centrifuged at 16,000 × g, at 4 °C for 10 min in a microcentrifuge and
each supernatant was loaded to a HLB cartridge (each cartridge was preconditioned
with 1 mL of 70% acetonitrile prior to use) to deplete phospholipids. After sample
loading, the ﬂow-through fraction was collected in a new tube. Subsequently, each
cartridge was washed with 300 µL of 70% acetonitrile, and the ﬂow-fractions were
pooled and dried with nitrogen. Dried samples were stored at −20 °C until use.
Serum and colon samples were reconstituted in 50 and 600 µL of 50% methanol,
respectively. Serum and colon samples were analyzed in random order in two
separate runs. We used a modiﬁed protocol from our previous study58: for each
sample, a volume of 2 µL was injected into an ultra-performance liquid
chromatography quadrupole time-of-ﬂight mass spectrometry (UPLC-QTOF-MS)
system consisting of a Dionex Ultimate 3000 RS liquid chromatograph (Thermo
Scientiﬁc, CA, USA) coupled to a Bruker maXis time- of-ﬂight mass spectrometer
equipped with an electrospray interphase (Bruker Daltonics, Bremen, Germany)
operating in negative mode. The analytes were separated on a Poroshell 120 SB-
C18 column with a dimension of 2.1 × 100 mm and 2.7-µm particle size (Agilent
Technologies, CA, USA). The column was held at 30 °C and the sampler at 4 °C.
The UPLC mobile phases consisted of 0.01% acetic acid in water (solution A) and
acetonitrile (solution B). The analytes were eluted using the following gradient:
Solvent programming started with a linear gradient from 10 to 25% B in 10 min at
a ﬂow rate of 0.3 mLmin−1. The ﬂow rate was then increased to 0.4 mLmin−1 as
the gradient went from 25 to 60% B until 18 min, where the gradient was increased
to 98% B until 20 min. The gradient was kept constant at 98% B until 23 min,
where the ﬂow rate was decreased to 0.3 mLmin−1. The gradient was returned to
initial conditions at 23.1 min and re-equilibrated until 25 min. Mass spectrometry
data were collected in full scan mode at 2 Hz with a scan range of 50–1000 mass/
charge (m/z). The following electrospray interphase settings were used: nebulizer
pressure 2 bar, drying gas 10 L min−1, 200 °C and capillary voltage 4500 V. To
improve the measurement accuracy, external and internal calibrations were done
using sodium acetate clusters (Sigma-Aldrich, Schnelldorf, Germany) and in
addition a lock-mass calibration was applied (hexakis(1H,1H,2H,perﬂuoroetoxy)
phosphazene, Apollo Scientiﬁc, Manchester, UK).
Bile acids were detected by extraction of ion chromatograms using the exact
mass of the bile acids ± 0.002 Da and quantiﬁed by use of standard curves and IS
with similar retention times as listed in Table S1. Data were processed using
QuantAnalysis version 2.2 (Bruker Daltonics, Bremen, Germany) and calibration
curves were established by plotting the peak area ratios of all of the analytes with
respect to the IS against the concentrations of the calibration standards. The
calibration curves were ﬁtted to quadratic regression.
Faecal bacterial load. Serial dilutions of fresh faecal samples collected from dams
2 days before expected delivery (D0W) were prepared in peptone saline diluent and
plated on Wilkins-Chalgren agar (WCA, Oxoid) and plate count agar (PCA,
Oxoid). Plates were incubated at 37 °C for 2 days under anaerobic and aerobic
conditions, respectively, before enumeration.
ELISA. Blood serum levels of haptoglobin and GLP-1 in 4-week-old rat pups
(P4W) were determined by use of commercial sandwich ELISA assays (EKR750
and EKR1992, respectively, Nordic BioSite ApS, Sweden) as recommended by the
supplier. Serum samples for haptoglobin measurements were diluted 1:500 and for
GLP-1 1:2. All samples were at least assayed in duplicates.
Data handling and statistics. All statistical analysis was conducted in GraphPad
Prism 7 (GraphPad Software Inc., La Jolla, CA) unless otherwise stated. Generally,
the unpaired t test or the non-parametric Mann–Whitney test, when appropriate,
was used to determine differences between the control group and treatment groups.
Animal weight of the pups was calculated by averaging the individual weights of all
pups in the appropriate cage. Average food intake per animal per day was calcu-
lated by dividing the total food intake with the number of animals per cage and the
number of days between measurements. Statistical analysis of the 16S rRNA gene
sequencing data to identify differentially represented bacterial groups was per-
formed by permutation-based t tests with 10,000 iterations in R, and correction for
multiple testing by the Benjamini–Hochberg false discovery rate method64. Dif-
ferences in total concentration of serum bile acids in pups at the different time
points and between the three groups of dams, respectively, were tested by one-way
ANOVA with Tukey’s multiple comparison test. For multivariate analysis of bile
acids, the data were auto-scaled and imported into LatentiX (version 2.11)
(Latent5) for PCA to assess the variation of the data. Spearman’s rank correlation
coefﬁcients were determined to investigate associations between the relative
abundance of bacterial genera, alpha-diversity, SCFAs and gene expression as well
as between bile acids and FXR and TGR5 gene expression.
Data availability
The 16S rRNA gene sequence datasets generated during the current study are deposited
in the NCBI Sequence Read Archive with the accession number SRP131746. All other
relevant data are available from the authors.
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